|
Survey:
A third of states weighing moves to spend less on drugs
MedCity
News
As
they grapple with the economic fallout of COVID-19, about one-third of U.S.
states are experimenting with price-control measures for prescription
drugs. But it’s unclear whether the controls will hold up to legal
challenges, according to a first-of-its-kind survey on the state efforts.
The controls revolve around state-created drug affordability boards, which
are tasked with reining in state spending on prescription drugs.
|
No comments:
Post a Comment